Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: An early glimpse into a challenging initiative U.S. Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Sunday, September 15, 2013

Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: An early glimpse into a challenging initiative U.S.



Open access

 Highlights
Quality measures are mandated to be reported at certain cancer hospitals.
National Quality Forum-endorsed gynecologic cancer quality measures do not exist.
Efforts to determine which specific quality measures are valuable in gynecologic cancer care is imperative.

In summary, while the importance of quality gynecologic cancer care is widely recognized as the means by which patients will receive optimal care, the current state of knowledge regarding the specific measures that are important to gynecologic oncologists is less clear. Despite mandatory reporting of some quality measures by PPS-exempt cancer hospitals, it is imperative that discussions amongst providers of gynecologic cancer continue towards the creation of national registries that can begin to define important quality measures.

 

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.